Report on scope and limitations of in vivo and in vitro non-clinical and computational models for drug milk excretion and breastfed infant exposure; Selection of a panel of at least 10 model compounds for initial evaluation of non-clinical models (D3.1)

This deliverable will reveal the advantages and limitations of the current state-of-the-art, which will serve as a starting point for the development of a non-clinical testing platform to study the transfer of medicines during lactation